MediWound Ltd. (MDWD)


+0.21 (+1.96%)
Symbol MDWD
Price $10.92
Beta 0.980
Volume Avg. 0.06M
Market Cap 103.463M
Shares () -
52 Week Range 8.05-17.08
1y Target Est -
DCF Unlevered MDWD DCF ->
DCF Levered MDWD LDCF ->
ROE 2027.61% Strong Buy
ROA -57.03% Strong Sell
Operating Margin -
Debt / Equity 1626.15% Strong Buy
P/E -3
P/B 1,545.51 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest MDWD news

Mr. Ofer Gonen B.Sc.
NASDAQ Global Market

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.